Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis.

Spring LM, Fell G, Arfe A, Sharma C, Greenup RA, Reynolds KL, Smith BL, Alexander BM, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A.

Clin Cancer Res. 2020 Feb 11. pii: clincanres.3492.2019. doi: 10.1158/1078-0432.CCR-19-3492. [Epub ahead of print]

PMID:
32046998
2.

Laser Treatment of Traumatic Scars and Contractures: 2020 International Consensus Recommendations.

Seago M, Shumaker PR, Spring LK, Alam M, Al-Niaimi F, Rox Anderson R, Artzi O, Bayat A, Cassuto D, Chan HH, Dierickx C, Donelan M, Gauglitz GG, Leo Goo B, Goodman GJ, Gurtner G, Haedersdal M, Krakowski AC, Manuskiatti W, Norbury WB, Ogawa R, Ozog DM, Paasch U, Victor Ross E, Tretti Clementoni M, Waibel J.

Lasers Surg Med. 2020 Feb;52(2):96-116. doi: 10.1002/lsm.23201. Epub 2019 Dec 9.

PMID:
31820478
3.

Ablative Fractional Laser Resurfacing: A Novel Treatment for Hypergranulation Tissue.

Spring LK, Rohrer TE, Dover JS.

Dermatol Surg. 2019 Oct 11. doi: 10.1097/DSS.0000000000002223. [Epub ahead of print] No abstract available.

PMID:
31634256
4.

FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.

Drago JZ, Formisano L, Juric D, Niemierko A, Servetto A, Wander SA, Spring LM, Vidula N, Younger J, Peppercorn J, Yuen M, Malvarosa G, Sgroi D, Isakoff SJ, Moy B, Ellisen LW, Iafrate AJ, Arteaga CL, Bardia A.

Clin Cancer Res. 2019 Nov 1;25(21):6443-6451. doi: 10.1158/1078-0432.CCR-19-0138. Epub 2019 Aug 1.

PMID:
31371343
5.

Corrigendum to "Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study" [Lung Cancer 130 (2019) (April) 216-225].

Steffens CC, Elender C, Hutzschenreuter U, Dille S, Binninger A, Spring L, Jänicke M, Marschner N; TLK-Group (Tumour Registry Lung Cancer).

Lung Cancer. 2019 Sep;135:236. doi: 10.1016/j.lungcan.2019.07.013. Epub 2019 Jul 22. No abstract available.

6.

Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.

Medford AJ, Dubash TD, Juric D, Spring L, Niemierko A, Vidula N, Peppercorn J, Isakoff S, Reeves BA, LiCausi JA, Wesley B, Malvarosa G, Yuen M, Wittner BS, Lawrence MS, Iafrate AJ, Ellisen L, Moy B, Toner M, Maheswaran S, Haber DA, Bardia A.

NPJ Precis Oncol. 2019 Jul 16;3:18. doi: 10.1038/s41698-019-0090-5. eCollection 2019.

7.

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.

Goel S, Pernas S, Tan-Wasielewski Z, Barry WT, Bardia A, Rees R, Andrews C, Tahara RK, Trippa L, Mayer EL, Winer EP, Spring LM, Tolaney SM.

Clin Breast Cancer. 2019 Dec;19(6):399-404. doi: 10.1016/j.clbc.2019.05.010. Epub 2019 May 30.

PMID:
31235441
8.

Fingernail Abnormalities After a Systemic Illness.

Cantor AS, Spring LK, Crandall ML.

Fed Pract. 2019 Apr;36(4):188-190.

9.

Genetics to epigenetics: targeting histone deacetylases in hormone receptor-positive metastatic breast cancer.

Wander SA, Spring LM, Bardia A.

Lancet Oncol. 2019 Jun;20(6):746-748. doi: 10.1016/S1470-2045(19)30279-7. Epub 2019 Apr 27. No abstract available.

PMID:
31036469
10.

Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study.

Steffens CC, Elender C, Hutzschenreuter U, Dille S, Binninger A, Spring L, Jänicke M, Marschner N; TLK-Group (Tumour Registry Lung Cancer).

Lung Cancer. 2019 Apr;130:216-225. doi: 10.1016/j.lungcan.2019.02.026. Epub 2019 Feb 25. Erratum in: Lung Cancer. 2019 Sep;135:236.

11.

CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.

Spring LM, Wander SA, Zangardi M, Bardia A.

Curr Oncol Rep. 2019 Feb 26;21(3):25. doi: 10.1007/s11912-019-0769-3. Review.

12.

Skin-Colored Papules on the Chest.

Cantor AS, Crandall ML, Spring LK.

Fed Pract. 2018 Nov;35(11):38-39.

13.

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models.

Keklikoglou I, Cianciaruso C, Güç E, Squadrito ML, Spring LM, Tazzyman S, Lambein L, Poissonnier A, Ferraro GB, Baer C, Cassará A, Guichard A, Iruela-Arispe ML, Lewis CE, Coussens LM, Bardia A, Jain RK, Pollard JW, De Palma M.

Nat Cell Biol. 2019 Feb;21(2):190-202. doi: 10.1038/s41556-018-0256-3. Epub 2018 Dec 31.

14.

Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?

Zangardi ML, Spring LM, Nagayama A, Bardia A.

Expert Opin Investig Drugs. 2019 Feb;28(2):107-112. doi: 10.1080/13543784.2019.1555239. Epub 2018 Dec 17. Review.

PMID:
30507322
15.

Agminated heterogeneous papules on the neck.

Benson KA, Crandall M, Spring LK.

Cutis. 2018 Aug;102(2):E24-E26. No abstract available.

PMID:
30235370
16.

Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer.

Spring L, Niemierko A, Haddad S, Yuen M, Comander A, Reynolds K, Shin J, Bahn A, Brachtel E, Specht M, Smith BL, Taghian A, Jimenez R, Peppercorn J, Isakoff SJ, Moy B, Bardia A.

Breast Cancer Res Treat. 2018 Dec;172(3):733-740. doi: 10.1007/s10549-018-4959-8. Epub 2018 Sep 15.

17.

A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer.

Kwan TT, Bardia A, Spring LM, Giobbie-Hurder A, Kalinich M, Dubash T, Sundaresan T, Hong X, LiCausi JA, Ho U, Silva EJ, Wittner BS, Sequist LV, Kapur R, Miyamoto DT, Toner M, Haber DA, Maheswaran S.

Cancer Discov. 2018 Oct;8(10):1286-1299. doi: 10.1158/2159-8290.CD-18-0432. Epub 2018 Aug 13.

18.

Stevens-Johnson syndrome-like eruption from palbociclib in a patient with metastatic breast cancer.

Karagounis T, Vallurupalli M, Nathan N, Nazarian R, Vedak P, Spring L, Chen ST.

JAAD Case Rep. 2018 Apr 30;4(5):452-454. doi: 10.1016/j.jdcr.2017.12.015. eCollection 2018 Jun. No abstract available.

19.

Research Biopsies: An Integrative Review of the Experiences of Patients With Cancer.

Abraham E, Post K, Spring L, Malvarosa G, Tripp E, Peppercorn JM, Bardia A, Habin K.

Clin J Oncol Nurs. 2018 Jun 1;22(3):E71-E77. doi: 10.1188/18.CJON.E71-E77. Review.

PMID:
29781452
20.

Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer.

Spring L, Bardia A.

Clin Cancer Res. 2018 Jul 1;24(13):2981-2983. doi: 10.1158/1078-0432.CCR-18-0463. Epub 2018 Apr 23.

21.

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.

Condorelli R, Spring L, O'Shaughnessy J, Lacroix L, Bailleux C, Scott V, Dubois J, Nagy RJ, Lanman RB, Iafrate AJ, Andre F, Bardia A.

Ann Oncol. 2018 Mar 1;29(3):640-645. doi: 10.1093/annonc/mdx784.

22.

Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.

Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes KS, Isakoff SJ, Ellisen LW, Smith BL, Specht M, Moy B, Bardia A.

J Natl Compr Canc Netw. 2017 Oct;15(10):1216-1223. doi: 10.6004/jnccn.2017.0158.

PMID:
28982747
23.

Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.

von Verschuer U, Schnell R, Tessen HW, Eggert J, Binninger A, Spring L, Jänicke M, Marschner N; TLK-Group (Tumour Registry Lung Cancer).

Lung Cancer. 2017 Oct;112:216-224. doi: 10.1016/j.lungcan.2017.07.031. Epub 2017 Sep 12.

24.

Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer.

Zangardi ML, Spring LM, Blouin GC, Bardia A.

Expert Rev Clin Pharmacol. 2017 Nov;10(11):1169-1176. doi: 10.1080/17512433.2017.1376653. Epub 2017 Sep 18. Review.

PMID:
28875723
25.

Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.

Spring LM, Zangardi ML, Moy B, Bardia A.

Oncologist. 2017 Sep;22(9):1039-1048. doi: 10.1634/theoncologist.2017-0142. Epub 2017 Jul 13. Review.

26.

Recalcitrant genital papules.

Bartels A, Crandall M, Spring L.

J Fam Pract. 2017 Jul;66(7):457-460.

PMID:
28700763
27.

Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Gazourian L, Spring L, Meserve E, Hwang D, Diaz AA, Ash SY, Ho VT, Sholl LM, Washko GR.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1767-1772. doi: 10.1016/j.bbmt.2017.06.009. Epub 2017 Jun 28.

28.

Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations.

Spring LK, Krakowski AC, Alam M, Bhatia A, Brauer J, Cohen J, Del Rosso JQ, Diaz L, Dover J, Eichenfield LF, Gurtner GC, Hanke CW, Jahnke MN, Kelly KM, Khetarpal S, Kinney MA, Levy ML, Leyden J, Longaker MT, Munavalli GS, Ozog DM, Prather H, Shumaker PR, Tanzi E, Torres A, Velez MW, Waldman AB, Yan AC, Zaenglein AL.

JAMA Dermatol. 2017 Aug 1;153(8):802-809. doi: 10.1001/jamadermatol.2017.2077. Review.

PMID:
28658462
29.

ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin Use.

Waldman A, Bolotin D, Arndt KA, Dover JS, Geronemus RG, Chapas A, Iyengar S, Kilmer SL, Krakowski AC, Lawrence N, Prather HB, Rohrer TE, Schlosser BJ, Kim JYS, Shumaker PR, Spring LK, Alam M.

Dermatol Surg. 2017 Oct;43(10):1249-1262. doi: 10.1097/DSS.0000000000001166.

PMID:
28498204
30.

Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer - Results from the prospective German Tumour Registry Breast Cancer cohort study.

Schröder J, Fietz T, Köhler A, Petersen V, Tesch H, Spring L, Fleitz A, Jänicke M, Marschner N; TMK-Group (Tumour Registry Breast Cancer).

Eur J Cancer. 2017 Jul;79:139-148. doi: 10.1016/j.ejca.2017.03.031. Epub 2017 May 8.

31.

SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?

Spring L, Bardia A.

Lancet Oncol. 2017 May;18(5):564-565. doi: 10.1016/S1470-2045(17)30106-7. Epub 2017 Mar 15. No abstract available.

PMID:
28314690
32.

Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival.

Crombie J, Spring L, Li S, Soiffer RJ, Antin JH, Alyea EP 3rd, Glotzbecker B.

Biol Blood Marrow Transplant. 2017 Jan;23(1):113-118. doi: 10.1016/j.bbmt.2016.10.012. Epub 2016 Oct 24.

33.

Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014.

Spring LM, Marshall MR, Warner ET.

Cancer. 2017 Feb 1;123(3):401-409. doi: 10.1002/cncr.30378. Epub 2016 Oct 11.

34.

Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.

Bychkovsky BL, Guo H, Sutton J, Spring L, Faig J, Dagogo-Jack I, Battelli C, Houlihan MJ, Yeh TC, Come SE, Lin NU.

Oncologist. 2016 Dec;21(12):1495-1501. Epub 2016 Aug 22.

35.

Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.

Spring LM, Gupta A, Reynolds KL, Gadd MA, Ellisen LW, Isakoff SJ, Moy B, Bardia A.

JAMA Oncol. 2016 Nov 1;2(11):1477-1486. doi: 10.1001/jamaoncol.2016.1897. Review.

36.

'Am I really ready to go home?': a qualitative study of patients' experience of early discharge following an enhanced recovery programme for liver resection surgery.

Vandrevala T, Senior V, Spring L, Kelliher L, Jones C.

Support Care Cancer. 2016 Aug;24(8):3447-54. doi: 10.1007/s00520-016-3158-6. Epub 2016 Mar 19.

PMID:
26992408
38.

A geometric summertime rash.

Barrio V, Spring L, Pellman L.

Am Fam Physician. 2015 May 1;91(9):649-50. No abstract available.

39.

Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival.

Spring L, Li S, Soiffer RJ, Antin JH, Alyea EP 3rd, Glotzbecker B.

Biol Blood Marrow Transplant. 2015 Mar;21(3):509-16. doi: 10.1016/j.bbmt.2014.11.682. Epub 2014 Dec 5.

40.

Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques.

Morsbach F, Sah BR, Spring L, Puippe G, Gordic S, Seifert B, Schaefer N, Pfammatter T, Alkadhi H, Reiner CS.

Eur Radiol. 2014 Jul;24(7):1455-65. doi: 10.1007/s00330-014-3180-3. Epub 2014 May 12.

PMID:
24817083
41.

Impact of pass/fail grading on medical students' well-being and academic outcomes.

Spring L, Robillard D, Gehlbach L, Simas TA.

Med Educ. 2011 Sep;45(9):867-77. doi: 10.1111/j.1365-2923.2011.03989.x. Review.

PMID:
21848714
42.

Control of magnetic ordering by Jahn--Teller distortions in Nd(2)GaMnO(6) and La(2)GaMnO(6).

Cussen EJ, Rosseinsky MJ, Battle PD, Burley JC, Spring LE, Vente JF, Blundell SJ, Coldea AI, Singleton J.

J Am Chem Soc. 2001 Feb 14;123(6):1111-22.

PMID:
11456664
43.

Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.

Williams DL, Spring L, Harris E, Roche P, Gillis TP.

Antimicrob Agents Chemother. 2000 Jun;44(6):1530-7. Erratum in: Antimicrob Agents Chemother 2001 Feb;45(2):647.

44.

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

Williams DL, Spring L, Collins L, Miller LP, Heifets LB, Gangadharam PR, Gillis TP.

Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7.

46.

Supplemental Content

Loading ...
Support Center